Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222af7
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 71M | $73M | -7% | Sep 2024 |
|
| Steelhead Partners | 55M | $57B | 9% | Sep 2024 |
|
| MacKay Shields | 31M | $32M | 100% | Sep 2024 |
|
| BlackRock | 23M | $24M | 100% | Sep 2024 |
|
| Calamos Advisors | 17M | $18M | 0% | Sep 2024 |
|
| BlackRock | 17M | $18M | 100% | Jun 2024 |
|
| Polar Securities | 15M | $16M | -50% | Sep 2024 |
|
| CNH Partners | 13M | $14M | -40% | Sep 2024 |
|
| CSS | 13M | $13M | 100% | Sep 2024 |
|
| Wells Fargo & Company | 12M | $13M | 76% | Sep 2024 |
|
| Readystate Asset Management | 10M | $10M | 0% | Sep 2024 |
|
| State Street Corporation | 8.4M | $9.3M | 100% | Jun 2024 |
|
| Shenkman Capital Management | 5.4M | $5.7B | 100% | Sep 2024 |
|
| Bank of America Corporation | 4.8M | $5.0M | 100% | Sep 2024 |
|
| RWC Asset Management | 3.7M | $3.8M | 0% | Sep 2024 |
|
| Amundi | 3.3M | $3.3M | 100% | Sep 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 3.3M | $3.4M | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 3.2M | $3.4M | 100% | Sep 2024 |
|
| Royal Bank of Canada | 3.2M | $3.4M | -44% | Sep 2024 |
|
| Bnp Paribas Investment Partners | 2.5M | $2.6M | 0% | Sep 2024 |
|
| Liberty Mutual Group Asset Management | 2.0M | $2.2M | 100% | Jun 2024 |
|
| Jump Financial | 2.0M | $2.1M | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.8M | $1.8M | 99% | Sep 2024 |
|
| Invesco | 1.5M | $1.6M | -9% | Sep 2024 |
|
| Man Group | 1.4M | $1.4M | -29% | Sep 2024 |
|
| Agf Management | 1.0M | $1.1M | 100% | Sep 2024 |
|
| Westwood Holdings | 1.0M | $104M | 100% | Sep 2024 |
|
| Barclays | 792k | $819k | 18% | Sep 2024 |
|
| Citigroup | 371k | $384k | -88% | Sep 2024 |
|
| Zurcher Kantonalbank | 300k | $308k | -50% | Sep 2024 |
|
| Sei Investments | 262k | $271k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 250k | $262k | 0% | Sep 2024 |
|
| KBC Group NV | 100k | $104k | 0% | Sep 2024 |
|
| Morgan Stanley | 31k | $34k | 100% | Jun 2024 |
|
| Context Capital Management | 5.0k | $5.2M | 0% | Sep 2024 |
|
Who sold out of Ionis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2024 | 22M | $24M |
| Citadel Advisors | Jun 2024 | 12M | $14M |
| Tenor Capital Management | Jun 2024 | 10M | $11B |
| Advent Capital Management | Jun 2024 | 7.3M | $8.1M |
| Groupama Asset Managment | Jun 2024 | 500k | $552k |